AIM IMMUNOTECH INC. Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31)
AIM IMMUNOTECH INC. (AIM) had Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) of $13.55 million as of 2013-09-30, per its 10-Q filed 2013-11-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesFairValueDisclosure · last filed 2013-11-08
- 2013-09-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $13.55M.
- 2013-06-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $16.84M.
- 2013-03-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $21.41M.
- 2012-12-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $27.24M.
| Period end | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) |
|---|---|
| 2013-09-30 | $13.55M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $16.84M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $21.41M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $27.24M 10-Q · filed 2013-11-08 |
| 2012-09-30 | $21.90M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $19.44M 10-Q · filed 2012-08-08 |
| 2011-12-31 | $28.19M 10-K · filed 2013-03-18 |
| 2010-12-31 | $41.47M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |